Revvity, Inc.'s SEC filings document operating results, governance matters and capital-structure disclosures for a Massachusetts-incorporated life sciences and diagnostics company. Its 8-K reports furnish quarterly and annual financial results, preliminary performance updates, Regulation FD investor presentation materials and other material-event disclosures.
Proxy and annual-meeting filings describe director elections, auditor ratification, advisory executive-compensation votes and shareholder-approved bylaw amendments, including the ability of holders of 25% of the company's stock to call a special meeting. Other current reports identify registered securities, including RVTY common stock and 1.875% notes due 2026 listed on the New York Stock Exchange, as well as officer appointments and related governance changes.
Revvity, Inc. (RVTY) common stock was the subject of T. Rowe Price Associates, Inc.’s fifth Schedule 13G amendment. The reporting person’s ownership table lists 13,204,725 shares, or 11.8% of the class, as of September 30, 2026. T. Rowe Price Associates, Inc. stated that the filing should not be construed as an admission of beneficial ownership and expressly denied such ownership. Ellen York, Vice President, signed for the reporting person.
Revvity, Inc. VP and CAO Anita Gonzales reported selling 84 shares of common stock on October 1, 2026, at $155.48 per share. The sale was made under a Rule 10b5-1 trading plan she adopted on November 7, 2025. Her reported direct holdings after the sale were 7,117 shares.
REVVITY, INC. (RVTY) lists Officer Anita Gonzales as proposing to sell 84 shares of common stock, with an aggregate market value of $13,060.32. Fidelity Brokerage Services LLC is listed as broker, October 1, 2026, as the approximate sale date, and NYSE as the exchange. The notice also reports 85 shares sold on July 20, 2026, for $9,305.80 during the prior three months. Jennifer Ruchti signed as an authorized representative of Fidelity Brokerage Services LLC and attorney-in-fact for Anita Gonzales.
Revvity, Inc. (RVTY) Senior Vice President and Chief Financial Officer Maxwell Krakowiak reported selling 1,631 common shares on September 21, 2026, at $144.53 per share. The sale was made under a 10b5-1 trading plan adopted May 19, 2026. He directly held 14,781 shares after the transaction.
REVVITY, INC. (RVTY) has a notice filed on behalf of shareholder Maxwell Krakowiak for a potential sale of up to 1,631 shares of common stock under Rule 144, through Fidelity Brokerage Services LLC on the NYSE, with an indicated aggregate market value of 235,728.43 as of the notice.
The shares relate to restricted stock that vested on March 16, 2023 (39 shares), February 15, 2024 (156 shares), February 15, 2025 (92 shares), and September 15, 2025 (1,344 shares), all issued as compensation by the company.
REVVITY, INC. (RVTY) officer Tajinder S. Vohra, Senior Vice President, Global Operations, reported selling 7,330 shares of common stock on September 16, 2026 at $140.88 per share in an open-market or private transaction. After this sale, Vohra directly holds 6,635 shares of REVVITY common stock. The sale was effected pursuant to a Rule 10b5-1 trading plan adopted on May 15, 2026, indicating the transaction was pre-arranged under that plan.
REVVITY, INC. (RVTY) has a notice under Rule 144 that officer Tajinder S. Vohra plans to sell up to 7,330 shares of common stock through Fidelity Brokerage Services LLC on the NYSE. The shares have an aggregate market value of $1,032,650.40 based on the filing calculation.
The shares derive from restricted stock vesting awards, including 4,961 shares vesting on January 30, 2023; 734 shares vesting on February 4, 2026; and 1,635 shares vesting on February 16, 2026. Common shares outstanding were 111,586,401 as of September 16, 2026; this is a baseline figure, not the amount being sold.
REVVITY, INC. (RVTY) is reported as having 10,261,343 shares of its common stock beneficially held by T. Rowe Price Investment Management, Inc., representing 9.2% of the outstanding class. T. Rowe Price Investment Management has sole power to vote 9,612,201 shares and sole power to dispose of 10,261,343 shares, with no shared voting or dispositive power.
The filing states that T. Rowe Price Investment Management acts as investment adviser for its clients and that the ultimate power to receive dividends and sale proceeds rests with those clients. T. ROWE PRICE CAPITAL APPRECIATION FUND is identified as holding 5,702,640 shares, or 5.1% of the class, within this total position.
REVVITY, INC. (RVTY) director Alexis P. Michas reported a bona fide gift of 285 shares of common stock made by The Cayre and Alexis Michas Foundation Corp. to a charitable organization. Following this, the foundation holds 6,985 shares indirectly, Michas holds 63,780 shares directly (including dividend-related shares in a Deferred Compensation Plan), and a spouse IRA holds 500 shares indirectly. The reporting person disclaims beneficial ownership of the foundation-held shares except to any extent of pecuniary interest.
REVVITY, INC. (RVTY) officer Joel S. Goldberg reported two related stock transfers involving Common Stock. Goldberg made a bona fide gift of 27,785 shares from his direct holdings, reducing his directly held shares to 13,729. The same 27,785 shares were received as a gift by an entity classified as indirectly owned, the Goldberg Irrevocable 2021 Trust, which held 91,494 shares after the transfer. The trust is for the sole benefit of Goldberg’s children, with his spouse as trustee, and Goldberg disclaims beneficial ownership of those trust shares except to any pecuniary interest, if any.